menu_open
Columnists Actual . Favourites . Archive
We use cookies to provide some features and experiences in QOSHE

More information  .  Close
Aa Aa Aa
- A +

AstraZeneca encounters a surge in shares as profits exceed expectations, buoyed by demand for cancer drugs

41 1
25.04.2024
Astra's shares rose as much as 6.5% in early London trading, the most in over three years. 

© Fortune


Get it on Google Play